Exploring the Link Between Inflammatory Biomarkers (SII, SIRI, PLR, NLR, LMR) and Migraine in Young and Early Middle-Aged US Adults: Evidence From NHANES 1999-2004 and Machine Learning Models.

Researchers investigated whether certain blood markers related to inflammation could help identify people at risk for migraines. Using data from over 8,000 young and middle-aged American adults, they examined five different inflammation markers calculated from routine blood tests. The study found that people with migraines had significantly higher levels of one specific marker called the Lymphocyte-to-Monocyte Ratio (LMR), which measures the balance between two types of white blood cells. Interestingly, the other four inflammation markers showed no difference between people with and without migraines. The researchers used advanced computer models to confirm their findings, with LMR emerging as the most important factor for predicting migraine risk. People with higher LMR levels had about 1.5 times greater odds of experiencing migraines. This finding suggests that a simple blood test could potentially help identify individuals at higher risk for migraines before symptoms become severe. For patients considering acupuncture, this research supports the connection between immune system function and migraines, which aligns with acupuncture's known effects on regulating inflammation and immune responses. Traditional Chinese medicine has long recognized the role of internal imbalances in headache conditions, and acupuncture has demonstrated effectiveness in reducing migraine frequency and severity in clinical studies. If you're exploring acupuncture for migraine management, seek a licensed acupuncturist with specific experience treating headache disorders.

This cross-sectional study analyzed NHANES 1999-2004 data to examine associations between five inflammatory biomarkers (SII, SIRI, PLR, NLR, LMR) and migraine prevalence in young and early middle-aged adults. Among participants, only Lymphocyte-to-Monocyte Ratio (LMR) demonstrated significant elevation in migraine patients (mean difference: 0.37, p<0.001). Multivariable logistic regression revealed a positive correlation between LMR and migraine risk (OR=1.51, 95% CI: 1.14-2.00, p=0.009), with threshold analysis showing linear relationship up to LMR value of 1.61. Nine machine learning models were employed, with LightGBM achieving highest performance (AUROC: 0.9198, recall: 93.3%). SII, SIRI, NLR, and PLR showed no significant associations with migraine status. Clinical takeaway: LMR may serve as a novel biomarker for migraine risk stratification, potentially informing integrated treatment approaches. The lymphocyte-monocyte balance warrants consideration when developing comprehensive migraine management protocols, including acupuncture interventions targeting immune modulation.